Weight Loss Peptides

3 peptides in this category

Semaglutide

Also: Ozempic, Wegovy, Rybelsus

A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely used for weight management. One of the most studied peptides with extensive clinical trial data.

GLP-1 AgonistsWeight LossMetabolic

Retatrutide

Also: LY3437943, Triple G

investigational

An investigational triple agonist targeting GIP, GLP-1, and glucagon receptors. Phase 3 trials show potential for up to 24% body weight reduction, making it the most potent obesity treatment in development.

Glucagon AgonistsWeight LossMetabolic

Tirzepatide

Also: Mounjaro, Zepbound

FDA-approved

A dual GIP/GLP-1 receptor agonist that has shown superior weight loss results compared to other GLP-1 agonists. FDA-approved for both type 2 diabetes and chronic weight management.

GIP AgonistsWeight LossMetabolic